AUREALIS OY
🇫🇮Finland
- Country
- 🇫🇮Finland
- Ownership
- Holding
- Established
- 2010-04-01
- Employees
- 1
- Market Cap
- -
Evaluation of AUP12602-C as New Topical Treatment for DFUs (DIAMEND STUDY)
Phase 2
Recruiting
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Biological: AUP1602-COther: Placebo
- First Posted Date
- 2023-11-01
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- Aurealis Oy
- Target Recruit Count
- 60
- Registration Number
- NCT06111183
- Locations
- 🇵🇱
Mikomed, Łódź, Poland
🇵🇱Lecran Centrum Opieki Nad Ranami, Wrocław, Poland
🇮🇹Ospedale San Donato, Arezzo, Italy
Treatment of Diabetic Foot Ulcers With AUP1602-C
Phase 1
Completed
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Biological: AUP1602-C
- First Posted Date
- 2020-02-24
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Aurealis Oy
- Target Recruit Count
- 26
- Registration Number
- NCT04281992
- Locations
- 🇩🇪
Medizinische Hochschule Hannover (MHH) CRC Core Facility, Hannover, Germany
🇵🇱Mikomed, Łódź, Poland
© Copyright 2025. All Rights Reserved by MedPath